Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

8:41
 
Share
 

Manage episode 393432068 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.

Show notes
(00:31)
Could you provide us a little bit about your background?

(01:20)
Could you give us a brief overview of this assay?

(02:45)
What patients should have this test and when should it be performed?

(04:25)
Could you talk a little bit about alternative test options and how they compare to our ceramides test?

(05:58)
Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?

  continue reading

308 episodes

Artwork
iconShare
 
Manage episode 393432068 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.

Show notes
(00:31)
Could you provide us a little bit about your background?

(01:20)
Could you give us a brief overview of this assay?

(02:45)
What patients should have this test and when should it be performed?

(04:25)
Could you talk a little bit about alternative test options and how they compare to our ceramides test?

(05:58)
Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?

  continue reading

308 episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide